Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Die Diabetologie
Erschienen in: Die Diabetologie 3/2024

06.04.2024 | Ernährung | DDG Praxisempfehlungen

Empfehlungen zur Ernährungsprävention des Typ‑2‑Diabetes mellitus

verfasst von: Prof. Dr. Thomas Skurk, Arthur Grünerbel, Sandra Hummel, Stefan Kabisch, Winfried Keuthage, Karsten Müssig, Helmut Nussbaumer, Diana Rubin, Marie-Christine Simon, Astrid Tombek, Katharina S. Weber, die Arbeitsgruppe Diabetes & Schwangerschaft der DDG

Erschienen in: Die Diabetologie | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Auszug

Auf der Webseite der Deutschen Diabetes Gesellschaft (https://​www.​ddg.​info/​behandlung-leitlinien/​leitlinien-praxisempfehlung​en) befinden sich alle PDFs zum kostenlosen Download. …
Literatur
1.
Lindström J, Neumann A, Sheppard KE et al (2010) Take action to prevent diabetes—the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 42(1):S37–S55PubMedCrossRef
2.
Skurk T, Bosy-Westphal A, Grünerbel A et al (2022) Dietary recommendations for persons with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 130(1):S151–S184PubMed
3.
McNaughton SA, Mishra GD, Brunner EJ (2008) Dietary patterns, insulin resistance, and incidence of type 2 diabetes in the Whitehall II study. Diabetes Care 31:1343–1348PubMedPubMedCentralCrossRef
4.
Benziger CP, Roth GA, Moran AE (2016) The global burden of disease study and the preventable burden of NCD. gh 11:393–397CrossRef
5.
Uusitupa M, Khan TA, Viguiliouk E et al (2019) Prevention of type 2 diabetes by lifestyle changes: a systematic review and meta-analysis. Nutrients 11:2611PubMedPubMedCentralCrossRef
6.
Haw JS, Galaviz KI, Straus AN et al (2017) Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med 177:1808–1817PubMedPubMedCentralCrossRef
7.
Howell S, Kones R (2017) “Calories in, calories out” and macronutrient intake: the hope, hype, and science of calories. Am J Physiol Endocrinol Metab 313:E608–E612PubMedCrossRef
8.
Willett W, Rockström J, Loken B et al (2019) Food in the anthropocene: the EAT-Lancet commission on healthy diets from sustainable food systems. Lancet 393:447–492PubMedCrossRef
9.
Nelson ME, Hamm MW, Hu FB et al (2016) Alignment of healthy dietary patterns and environmental sustainability: a systematic review. Adv Nutr 7:1005–1025PubMedPubMedCentralCrossRef
10.
Poole MK, Musicus AA, Kenney EL (2020) Alignment of US school lunches with the EAT-lancet healthy reference diet’s standards for planetary health. Health Aff 39:2144–2152CrossRef
11.
Goulding T, Lindberg R, Russell CG (2020) The affordability of a healthy and sustainable diet: an Australian case study. Nutr J 19:109PubMedPubMedCentralCrossRef
12.
Breidenassel C, Schäfer AC, Micka M et al (2022) The planetary health diet in contrast to the food-based dietary guidelines of the German nutrition society (DGE). A DGE statement. Ernahr Umsch 59:56–72.e1‑3
13.
Beal T, Ortenzi F, Fanzo J (2023) Estimated micronutrient shortfalls of the EAT-Lancet planetary health diet. Lancet Planet Health 7:e233–e237PubMedCrossRef
14.
Delgermaa D, Yamaguchi M, Nomura M (2023) Assessment of Mongolian dietary intake for planetary and human health. PLoS Glob Public Health 3:e1229PubMedPubMedCentralCrossRef
15.
Marchion DM, Cacau LT, de Carli E et al (2022) Low adherence to the EAT-lancet sustainable reference diet in the Brazilian population: findings from the national dietary survey 2017–2018. Nutrients 14:1187CrossRef
16.
Nomura M, Yamaguchi M, Inada Y et al (2023) Current dietary intake of the Japanese population in reference to the planetary health diet-preliminary assessment. Front Nutr 10:1116105PubMedPubMedCentralCrossRef
17.
Ojo O, Jiang Y, Ojo O et al (2023) The association of planetary health diet with the risk of type 2 diabetes and related complications: a systematic review. Healthcare 11:1120PubMedPubMedCentralCrossRef
18.
Cacau LT, Benseñor IM, Goulart AC et al (2021) Adherence to the planetary health diet index and obesity indicators in the Brazilian longitudinal study of adult health (ELSA-Brasil). Nutrients 13:3691PubMedPubMedCentralCrossRef
19.
Rehner J, Schmartz GP, Kramer T et al (2023) The effect of a planetary health diet on the human gut microbiome: a descriptive analysis. Nutrients 15:1924PubMedPubMedCentralCrossRef
20.
Laine JE, Huybrechts I, Gunter MJ et al (2021) Co-benefits from sustainable dietary shifts for population and environmental health: an assessment from a large European cohort study. Lancet Planet Health 5:e786–e796PubMedPubMedCentralCrossRef
21.
González CA, Bonet C, Huerta JM et al (2022) Dietary greenhouse gas emissions and the risk of coronary heart disease and type 2 diabetes. Lancet Planet Health 6:e299PubMedCrossRef
22.
Berthy F, Brunin J, Allès B et al (2023) Higher adherence to the EAT-Lancet reference diet is associated with higher nutrient adequacy in the NutriNet-Santé cohort: a cross-sectional study. Am J Clin Nutr 117:1174–1185PubMedCrossRef
23.
López GE, Batis C, González C et al (2023) EAT-Lancet healthy reference diet score and diabetes incidence in a cohort of Mexican women. Eur J Clin Nutr 77:S348–S355CrossRef
24.
25.
Mensink GBM, Schienkiewitz A, Haftenberger M et al (2013) Übergewicht und Adipositas in Deutschland: Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:786–794PubMedCrossRef
26.
Yuen MMA (2023) Health complications of obesity: 224 obesity-associated comorbidities from a mechanistic perspective. Gastroenterol Clin North Am 52:363–380PubMedCrossRef
27.
Tuomilehto J, Lindström J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef
28.
Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef
29.
Deedwania PC, Volkova N (2005) Current treatment options for the metabolic syndrome. Curr Treat Options Cardiovasc Med 7:61–74PubMedCrossRef
30.
UKPDS Group (1990) UK prospective diabetes study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients. Metabolism 39:905–912CrossRef
31.
Goodpaster BH, Krishnaswami S, Resnick H et al (2003) Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26:372–379PubMedCrossRef
32.
Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 20:537–544PubMedCrossRef
33.
Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF et al (2009) 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet 374:1677–1686PubMedCentralCrossRef
34.
Diabetes Prevention Program Research Group (2015) Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study. Lancet Diabetes Endocrinol 3:866–875PubMedCentralCrossRef
35.
Chen Y, Zhang P, Wang J et al (2021) Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing diabetes prevention outcome study. Diabetologia 64:1279–1287PubMedCrossRef
36.
Fritsche A, Wagner R, Heni M et al (2021) Different effects of lifestyle intervention in high- and low-risk prediabetes: results of the randomized controlled prediabetes lifestyle intervention study (PLIS). Diabetes 70:2785–2795PubMedCrossRef
37.
Evert AB, Dennison M, Gardner CD et al (2019) Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 42:731–754PubMedPubMedCentralCrossRef
38.
Klein S, Sheard NF, Pi-Sunyer X et al (2004) Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American diabetes association, the north American association for the study of obesity, and the American society for clinical nutrition. Am J Clin Nutr 80:257–263PubMedCrossRef
39.
National Task Force on the Prevention and Treatment of Obesity, National Institutes of Health (1993) Very low-calorie diets. JAMA 270:967–974CrossRef
40.
Churuangsuk C, Hall J, Reynolds A et al (2022) Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. Diabetologia 65:14–36PubMedCrossRef
41.
42.
Kempf K, Altpeter B, Berger J et al (2017) Efficacy of the telemedical lifestyle intervention program TeLipro in advanced stages of type 2 diabetes: a randomized controlled trial. Diabetes Care 40:863–871PubMedCrossRef
43.
Su D, McBride C, Zhou J et al (2016) Does nutritional counseling in telemedicine improve treatment outcomes for diabetes? A systematic review and meta-analysis of results from 92 studies. J Telemed Telecare 22:333–347PubMedCrossRef
44.
Halvorsen RE, Elvestad M, Molin M et al (2021) Fruit and vegetable consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective studies. BMJ Nutr Prev Health 4:519–531PubMedPubMedCentralCrossRef
45.
Li M, Fan Y, Zhang X et al (2014) Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies. BMJ Open 4:e5497PubMedPubMedCentralCrossRef
46.
Ahmed A, Lager A, Fredlund P et al (2020) Consumption of fruit and vegetables and the risk of type 2 diabetes: a 4-year longitudinal study among Swedish adults. J Nutr Sci 9:e14PubMedPubMedCentralCrossRef
47.
Satija A, Bhupathiraju SN, Rimm EB et al (2016) Plant-based dietary patterns and incidence of type 2 diabetes in US men and women: results from three prospective cohort studies. PLoS Med 13:e1002039PubMedPubMedCentralCrossRef
48.
InterAct Consortium (2015) Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct study and a meta-analysis of prospective studies. Diabetologia 58:1394–1408CrossRef
49.
Cooper AJ, Forouhi NG, Ye Z et al (2012) Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr 66:1082–1092PubMedPubMedCentralCrossRef
50.
Hughes J, Pearson E, Grafenauer S (2022) Legumes—a comprehensive exploration of global food-based dietary guidelines and consumption. Nutrients 14:3080PubMedPubMedCentralCrossRef
51.
Bielefeld D, Grafenauer S, Rangan A (2020) The effects of legume consumption on markers of glycaemic control in individuals with and without diabetes mellitus: a systematic literature review of randomised controlled trials. Nutrients 12:2123PubMedPubMedCentralCrossRef
52.
Pearce M, Fanidi A, Bishop TRP et al (2021) Associations of total legume, pulse, and soy consumption with incident type 2 diabetes: federated meta-analysis of 27 studies from diverse world regions. J Nutr 151:1231–1240PubMedPubMedCentralCrossRef
53.
Papakonstantinou E, Galanopoulos K, Kapetanakou AE et al (2022) Short-term effects of traditional Greek meals: lentils with lupins, Trahana with tomato sauce and halva with currants and dried figs on postprandial glycemic responses—a randomized clinical trial in healthy humans. Int J Environ Res Public Health 19:11502PubMedPubMedCentralCrossRef
54.
Afshin A, Micha R, Khatibzadeh S et al (2014) Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am J Clin Nutr 100:278–288PubMedPubMedCentralCrossRef
55.
Hosseinpour-Niazi S, Mirmiran P, Fallah-Ghohroudi A et al (2015) Non-soya legume-based therapeutic lifestyle change diet reduces inflammatory status in diabetic patients: a randomised cross-over clinical trial. Br J Nutr 114:213–219PubMedCrossRef
56.
George ES, Daly RM, Tey SL et al (2022) Perspective: is it time to expand research on “nuts” to include “seeds”?. Justifications and key considerations. Adv Nutr 13:1016–1027PubMedPubMedCentralCrossRef
57.
Khalili L, A‑Elgadir TME, Mallick AK et al (2022) Nuts as a part of dietary strategy to improve metabolic biomarkers: a narrative review. Front Nutr 9:881843PubMedPubMedCentralCrossRef
58.
Blanco Mejia S, Kendall CWC, Viguiliouk E et al (2014) Effect of tree nuts on metabolic syndrome criteria: a systematic review and meta-analysis of randomised controlled trials. BMJ Open 4:e4660PubMedPubMedCentralCrossRef
59.
Martínez-González MA, García-Arellano A, Toledo E et al (2012) A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PLoS One 7:e43134PubMedPubMedCentralCrossRef
60.
Wu L, Wang Z, Zhu J et al (2015) Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis. Nutr Rev 73:409–425PubMedPubMedCentralCrossRef
61.
Johnston BC, Zeraatkar D, Han MA et al (2019) Unprocessed red meat and processed meat consumption: dietary guideline recommendations from the nutritional recommendations (NutriRECS) consortium. Ann Intern Med 171:756–764PubMedCrossRef
62.
63.
Ramachandran A, Snehalatha C, Mary S et al (2006) The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289–297PubMedCrossRef
64.
Uusitupa M, Louheranta A, Lindström J et al (2000) The Finnish diabetes prevention study. Br J Nutr 83(1):S137–S142PubMedCrossRef
65.
Dyson PA, Twenefour D, Breen C et al (2018) Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med 35:541–547PubMedCrossRef
66.
Imamura F, O’Connor L, Ye Z et al (2015) Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ 351:h3576PubMedPubMedCentralCrossRef
67.
ElSayed NA, Aleppo G, Aroda VR et al (2023) Summary of revisions: standards of care in diabetes—2023. Diabetes Care 46(1):S5–S9PubMedCrossRef
68.
Malik VS, Hu FB (2015) Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us. J Am Coll Cardiol 66:1615–1624PubMedPubMedCentralCrossRef
69.
Stern D, Mazariegos M, Ortiz-Panozo E et al (2019) Sugar-sweetened soda consumption increases diabetes risk among Mexican women. J Nutr 149:795–803PubMedCrossRef
70.
Gardener H, Rundek T, Wright CB et al (2012) Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke 43:1200–1205PubMedPubMedCentralCrossRef
71.
Huang M, Quddus A, Stinson L et al (2017) Artificially sweetened beverages, sugar-sweetened beverages, plain water, and incident diabetes mellitus in postmenopausal women: the prospective women’s health initiative observational study. Am J Clin Nutr 106:614–622PubMedPubMedCentralCrossRef
72.
Malik VS, Hu FB (2022) The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases. Nat Rev Endocrinol 18:205–218PubMedPubMedCentralCrossRef
73.
Geidl-Flueck B, Hochuli M, Németh Á et al (2021) Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: a randomized controlled trial. J Hepatol 75:46–54PubMedCrossRef
74.
GBD 2016 Alcohol Collaborators (2018) Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet 392:1015–1035PubMedCentralCrossRef
75.
Kulzer B, Albus C, Herpertz S et al (2020) Psychosoziales und Diabetes. Diabetol Stoffwechs 15(1):S232–S248
76.
Snijder MB, van der Heijden AA, van Dam RM et al (2007) Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study. Am J Clin Nutr 85:989–995PubMedCrossRef
77.
Soedamah-Muthu SS, Ding EL, Al-Delaimy WK et al (2011) Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr 93:158–171PubMedCrossRef
78.
Pereira MA, Jacobs DR, Van Horn L et al (2022) Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA study. JAMA 287:2081–2089CrossRef
79.
Azadbakht L, Mirmiran P, Esmaillzadeh A et al (2005) Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr 82:523–530PubMedCrossRef
80.
Elwood PC, Givens DI, Beswick AD et al (2008) The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer. J Am Coll Nutr 27:723S–734SPubMedCrossRef
81.
Ferland A, Lamarche B, Château-Degat ML et al (2011) Dairy product intake and its association with body weight and cardiovascular disease risk factors in a population in dietary transition. J Am Coll Nutr 30:92–99PubMedCrossRef
82.
Margolis KL, Wei F, de Boer ICH et al (2011) A diet high in low-fat dairy products lowers diabetes risk in postmenopausal women. J Nutr 141:1969–1974PubMedPubMedCentralCrossRef
83.
Wennersberg MH, Smedman A, Turpeinen AM et al (2009) Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study. Am J Clin Nutr 90:960–968PubMedCrossRef
84.
Wannamethee SG, Hu FB (2009) Obesity epidemiology. Int J Epidemiol 38:325–326CrossRef
85.
Tremblay A, Gilbert JA (2009) Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 28(1):91S–102SPubMedCrossRef
86.
McGlynn ND, Khan TA, Wang L et al (2022) Association of low- and no-calorie sweetened beverages as a replacement for sugar-sweetened beverages with body weight and cardiometabolic risk: a systematic review and meta-analysis. JAMA Netw Open 5:e222092PubMedPubMedCentralCrossRef
87.
Lee JJ, Khan TA, McGlynn N et al (2022) Relation of change or substitution of low- and no-calorie sweetened beverages with cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies. Diabetes Care 45:1917–1930PubMedPubMedCentralCrossRef
88.
Rogers PJ, Appleton KM (2021) The effects of low-calorie sweeteners on energy intake and body weight: a systematic review and meta-analyses of sustained intervention studies. Int J Obes 45:464–478CrossRef
89.
90.
Tiwaskar M, Mohan V (2022) Clearing the myths around non-nutritive/noncaloric sweeteners: an efficacy and safety evaluation. J Assoc Physicians India 70:11–12PubMed
91.
Daher MI, Matta JM, Abdel N et al (2019) Non-nutritive sweeteners and type 2 diabetes: should we ring the bell? Diabetes Res Clin Pract 155:107786PubMedCrossRef
92.
O’Connor D, Pang M, Castelnuovo G et al (2021) A rational review on the effects of sweeteners and sweetness enhancers on appetite, food reward and metabolic/adiposity outcomes in adults. Food Funct 12:442–465PubMedCrossRef
93.
Suez J, Cohen Y, Valdés-Mas R et al (2022) Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell 185:3307–3328.e19PubMedCrossRef
94.
Bayındır Gümüş A, Keser A, Tunçer E et al (2022) Effect of saccharin, a non-nutritive sweeteners, on insulin and blood glucose levels in healthy young men: a crossover trial. Diabetes Metab Syndr 16:102500PubMedCrossRef
95.
Meng Y, Li S, Khan J et al (2021) Sugar- and artificially sweetened beverages consumption linked to type 2 diabetes, cardiovascular diseases, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Nutrients 13:2636PubMedPubMedCentralCrossRef
96.
Ayoub-Charette S, McGlynn ND, Lee D et al (2023) Rationale, design and participants baseline characteristics of a crossover randomized controlled trial of the effect of replacing SSBs with NSBs versus water on glucose tolerance, gut microbiome and cardiometabolic risk in overweight or obese adult SSB consumer: strategies to oppose SUGARS with non-nutritive sweeteners or water (STOP sugars NOW) trial and ectopic fat sub-study. Nutrients 15:1238PubMedPubMedCentralCrossRef
97.
Pang MD, Goossens GH, Blaak EE (2020) The impact of artificial sweeteners on body weight control and glucose homeostasis. Front Nutr 7:598340PubMedCrossRef
98.
Neuenschwander M, Ballon A, Weber K et al (2019) Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ 366:l2368PubMedPubMedCentralCrossRef
99.
Neuenschwander M, Barbaresko J, Pischke CR et al (2020) Intake of dietary fats and fatty acids and the incidence of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective observational studies. PLoS Med 17:e1003347PubMedPubMedCentralCrossRef
100.
Li J, Glenn AJ, Yang Q et al (2022) Dietary protein sources, mediating biomarkers, and incidence of type 2 diabetes: findings from the women’s health initiative and the UK biobank. Diabetes Care 45:1742–1753PubMedPubMedCentralCrossRef
101.
Schlesinger S (2023) Diet and diabetes prevention: is a plant-based diet the solution? Diabetes Care 46:6–8PubMedCrossRef
102.
Ley SH, Hamdy O, Mohan V et al (2014) Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 383:1999–2007PubMedPubMedCentralCrossRef
103.
Qian F, Liu G, Hu FB et al (2019) Association between plant-based dietary patterns and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA Intern Med 179:1335–1344PubMedPubMedCentralCrossRef
104.
Lee Y, Park K (2017) Adherence to a vegetarian diet and diabetes risk: a systematic review and meta-analysis of observational studies. Nutrients 9:603PubMedPubMedCentralCrossRef
105.
Tonstad S, Stewart K, Oda K et al (2011) Vegetarian diets and incidence of diabetes in the adventist health study‑2. Nutr Metab Cardiovasc Dis 23:292–299PubMedPubMedCentralCrossRef
106.
Selinger E, Neuenschwander M, Koller A et al (2022) Evidence of a vegan diet for health benefits and risks—an umbrella review of meta-analyses of observational and clinical studies. Critical reviews in food science and nutrition
107.
108.
Koivusalo SB, Rönö K, Klemetti MM et al (2016) Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish gestational diabetes prevention study (RADIEL): a randomized controlled trial. Diabetes Care 39:24–30PubMedCrossRef
109.
Wang C, Wei Y, Zhang X et al (2017) A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women. Am J Obstet Gynecol 216:340–351PubMedCrossRef
110.
Griffith RJ, Alsweiler J, Moore AE et al (2020) Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane reviews. Cochrane Database Syst Rev 6:CD12394PubMed
111.
Tobias DK, Zhang C, van Dam RM et al (2011) Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis. Diabetes Care 34:223–229PubMedCrossRef
112.
Guo XY, Shu J, Fu XH et al (2019) Improving the effectiveness of lifestyle interventions for gestational diabetes prevention: a meta-analysis and meta-regression. BJOG 126:311–320PubMedCrossRef
113.
Chen Z, Qian F, Liu G et al (2021) Prepregnancy plant-based diets and the risk of gestational diabetes mellitus: a prospective cohort study of 14,926 women. Am J Clin Nutr 114:1997–2005PubMedPubMedCentralCrossRef
114.
Tieu J, Shepherd E, Middleton P et al (2017) Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus. Cochrane Database Syst Rev 1:CD6674PubMed
115.
Lamain-de Ruiter M, Kwee A, Naaktgeboren CA et al (2016) External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study. BMJ 354:i4338PubMedCrossRef
116.
Brunner S, Stecher L, Ziebarth S et al (2015) Excessive gestational weight gain prior to glucose screening and the risk of gestational diabetes: a meta-analysis. Diabetologia 58:2229–2237PubMedCrossRef
117.
Rasmussen KM, Yaktine AL (Hrsg) (2009) Weight gain during pregnancy. Reexamining the guidelines. National Academies Press, Washington
118.
Barnes RA, Wong T, Ross GP et al (2020) Excessive weight gain before and during gestational diabetes mellitus management: what is the impact? Diabetes Care 43:74–81PubMedCrossRef
119.
120.
Ouellette C, Rudkowska I, Lemieux S et al (2014) Gene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega‑3 polyunsaturated fatty acid supplementation: a clinical trial. Lipids Health Dis 13:86PubMedPubMedCentralCrossRef
121.
Vallée Marcotte B, Cormier H, Guénard F et al (2016) Novel genetic loci associated with the plasma triglyceride response to an omega‑3 fatty acid supplementation. J Nutrigenet Nutrigenomics 9:1–11PubMed
122.
Rudkowska I, Pérusse L, Bellis C et al (2015) Interaction between common genetic variants and total fat intake on low-density lipoprotein peak particle diameter: a genome-wide association study. J Nutrigenet Nutrigenomics 8:44–53PubMed
123.
Seidelmann SB, Feofanova E, Yu B et al (2018) Genetic variants in SGLT1, glucose tolerance, an cardiometabolic risk. J Am Coll Cardiol 72:1763–1773PubMedPubMedCentralCrossRef
124.
Hamman RF, Wing RR, Edelstein SL et al (2006) Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 29:2102–2107PubMedCrossRef
125.
Galaviz KI, Weber MB, Straus A et al (2018) Global diabetes prevention interventions: a systematic review and network meta-analysis of the real-world impact on incidence, weight, and glucose. Diabetes Care 41:1526–1534PubMedPubMedCentralCrossRef
Metadaten
Titel
Empfehlungen zur Ernährungsprävention des Typ‑2‑Diabetes mellitus
verfasst von
Prof. Dr. Thomas Skurk
Arthur Grünerbel
Sandra Hummel
Stefan Kabisch
Winfried Keuthage
Karsten Müssig
Helmut Nussbaumer
Diana Rubin
Marie-Christine Simon
Astrid Tombek
Katharina S. Weber
die Arbeitsgruppe Diabetes & Schwangerschaft der DDG
Publikationsdatum
06.04.2024
Verlag
Springer Medizin
Schlagwort
Ernährung
Erschienen in
Die Diabetologie / Ausgabe 3/2024
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI
https://doi.org/10.1007/s11428-024-01173-1

Weitere Artikel der Ausgabe 3/2024

Die Diabetologie 3/2024 Zur Ausgabe

Journal Club

Einfluss der Remission des Typ-2-Diabetes auf das kardiovaskuläre und renale Risiko

Journal Club

Metaanalyse zum Zusammenhang zwischen Diabetestherapie und Demenz

Übersichten

Post-COVID und Diabetes mellitus

Leitthema

Aktuelles zur Ernährungstherapie bei Adipositas

DDG Praxisempfehlungen

Empfehlungen zur Ernährung von Personen mit Typ-2-Diabetes mellitus

DDG Praxisempfehlungen

Adipositas und Diabetes

Passend zum Thema

ANZEIGE

Fatal verkannt: Vitamin-B12-Mangel frühzeitig behandeln!

Ernährung

Müdigkeit und Erschöpfung sind meist die ersten Symptome eines Vitamin-B12-Mangels. Wird das Defizit nicht rechtzeitig behandelt, drohen mitunter schwerwiegende Folgen. Lesen Sie hier, was bei der Therapie zu beachten ist.

ANZEIGE

Vitamin-B12-Mangel durch Arzneimittel

Ernährung

Einige häufig verordnete Medikamente wie das orale Antidiabetikum Metformin oder Protonenpumpeninhibitoren (PPI) können einen Mangel an Vitamin B12 verursachen. Bei einer Langzeitmedikation mit diesen Wirkstoffen sollte daher an ein mögliches Defizit gedacht werden. Erfahren Sie hier, worauf dabei zu achten ist.

ANZEIGE

Vitamin-B12-Mangel – Aktuelles Basiswissen für die Praxis.

Content Hub

Ein Mangel an Vitamin B12 tritt in bestimmten Risikogruppen häufig auf. Diese Patienten sind auch regelmäßig in Ihrer Praxis. Wird der Mangel nicht rechtzeitig behandelt, drohen mitunter schwerwiegende Folgen. Erhalten Sie hier einen Überblick über aktuelles Basiswissen für den Praxisalltag.

WÖRWAG Pharma GmbH & Co. KG
Bildnachweise